urinary retention - Nursing Case Study

Pathophysiology

• Primary mechanism: Bladder outlet obstruction - This occurs when there is a physical blockage at the bladder neck or urethra, often due to conditions like benign prostatic hyperplasia (BPH) or urethral stricture, leading to impaired urine flow and retention.

• Secondary mechanism: Detrusor muscle dysfunction - This involves impaired contractility of the bladder muscle due to neurological conditions (e.g., spinal cord injury, multiple sclerosis) or chronic overstretching of the bladder, resulting in inability to effectively expel urine.

• Key complication: Chronic urinary retention can lead to increased bladder pressure, causing hydronephrosis or renal damage if untreated, highlighting the importance of timely intervention in clinical practice.

Patient Profile

Demographics:

65-year-old male, retired construction worker

History:

• Key past medical history: Benign prostatic hyperplasia, hypertension

• Current medications: Tamsulosin, Lisinopril

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Difficulty urinating and lower abdominal pain

• Key symptoms: Incomplete bladder emptying, weak urine stream, nocturia, suprapubic discomfort

• Vital signs: Blood pressure 160/95 mmHg, heart rate 102 bpm, respiratory rate 20 breaths per minute, temperature 99.1°F (37.3°C)

Section 1

As Mr. Johnson's examination continues, the healthcare team notes a change in his status that requires prompt attention. The patient reports intensifying lower abdominal pain and a growing sense of urgency without the ability to void. Upon palpation, the nurse observes a distended bladder, indicating acute urinary retention. Mr. Johnson's blood pressure has elevated further to 165/100 mmHg, and he appears increasingly uncomfortable, with a heart rate now at 108 bpm. These findings suggest that the bladder outlet obstruction is worsening, potentially leading to more significant complications if not addressed promptly.

In response, a bladder scan is performed, revealing a post-void residual volume of 600 mL, confirming significant urinary retention. The healthcare provider orders a straight catheterization to relieve the discomfort and pressure, which leads to the drainage of 700 mL of urine, bringing Mr. Johnson temporary relief. However, laboratory results return showing a slightly elevated serum creatinine level of 1.5 mg/dL, raising concern for possible renal impairment due to the prolonged retention. This finding emphasizes the necessity for further investigation into kidney function and the underlying causes of Mr. Johnson's urinary retention.

These developments prompt the team to consider more invasive diagnostic measures, such as imaging studies, to assess for any structural abnormalities or complications like hydronephrosis. Additionally, the team must evaluate the effectiveness of Mr. Johnson's current medication regimen, particularly focusing on whether the dosage of Tamsulosin is appropriate or if alternative therapies might better address the progression of his benign prostatic hyperplasia. This scenario underscores the importance of continuous monitoring and timely intervention to prevent further renal damage and improve Mr. Johnson's quality of life.

Section 2

As the healthcare team continues to monitor Mr. Johnson, they decide to perform a renal ultrasound to further assess the potential impact of his urinary retention on kidney function. The ultrasound reveals mild hydronephrosis in the right kidney, suggesting that the prolonged bladder outlet obstruction has started to affect renal drainage. This finding is concerning and prompts the team to expedite a more comprehensive evaluation of Mr. Johnson's urinary tract, including a possible cystoscopy to directly visualize the bladder and urethra for any obstructive lesions or anatomical abnormalities.

In parallel, the clinical team reviews Mr. Johnson's medication regimen. Noting his continued symptoms despite being on Tamsulosin, they discuss the possibility of increasing the dose or adding another alpha-blocker to provide more effective relief of his benign prostatic hyperplasia symptoms. They also consider introducing a 5-alpha reductase inhibitor to reduce prostate size over the longer term. The team recognizes the importance of balancing these medications with Mr. Johnson’s current cardiovascular status, given his elevated blood pressure and heart rate, which remain at 160/98 mmHg and 105 bpm, respectively.

This evolving scenario emphasizes the necessity for quick decision-making and intervention to prevent further renal compromise. The team discusses the potential need for a urological referral to explore surgical options if medical management proves insufficient. This case highlights the intricacies involved in managing urinary retention and the interconnectedness of the urinary and renal systems, urging the team to remain vigilant in monitoring Mr. Johnson's condition while preparing for the next steps in his care plan.

Section 3

As the medical team moves forward with Mr. Johnson's care, they prioritize conducting the cystoscopy to gain a clearer picture of the underlying causes of his urinary retention. The procedure reveals a notable narrowing of the urethra due to benign prostatic hyperplasia (BPH) accompanied by trabeculation of the bladder wall, indicative of chronic bladder outlet obstruction. This finding underscores the urgency for more aggressive management to prevent further renal damage and improve Mr. Johnson's quality of life.

In parallel with the cystoscopy results, the team receives updated laboratory findings that add another layer of complexity to Mr. Johnson's condition. His serum creatinine level has risen to 1.8 mg/dL from a previous baseline of 1.2 mg/dL, suggesting worsening renal function. Additionally, his urinalysis shows microscopic hematuria and mild proteinuria, further supporting the presence of significant urinary tract complications. These lab results necessitate a reassessment of his treatment plan, emphasizing the importance of addressing both his BPH and renal implications concurrently.

Given the cystoscopy and lab findings, the healthcare team decides to initiate dual therapy with an increased dose of Tamsulosin and the addition of a 5-alpha reductase inhibitor. They remain cautious of potential side effects, particularly concerning Mr. Johnson's cardiovascular status. In light of his persistent hypertension and tachycardia, they also consult with a cardiologist to optimize his blood pressure management without exacerbating his urinary symptoms. The team continues to monitor Mr. Johnson closely, aware that surgical intervention may become necessary if medical management fails to yield significant improvement. This multifaceted approach reflects the complexity of his condition and underscores the need for coordinated care across specialties.

Section 4

As Mr. Johnson's treatment progresses, the healthcare team closely monitors his response to the dual therapy regimen. Initially, there is optimism as Mr. Johnson reports a slight improvement in urinary flow and a decrease in nocturia frequency. However, during a routine follow-up appointment, new complications arise that require immediate attention. Mr. Johnson presents with increased fatigue, mild dizziness, and a persistent headache, raising concerns about his cardiovascular status. His vital signs reveal a blood pressure of 150/95 mmHg and a heart rate of 105 beats per minute, indicating poorly controlled hypertension and persistent tachycardia despite the current medication adjustments.

Further diagnostic evaluation, including an ECG, shows signs of left ventricular hypertrophy, suggesting that his cardiovascular system is under significant strain. Additionally, repeat blood tests reveal a further increase in serum creatinine to 2.0 mg/dL, alongside a decrease in estimated glomerular filtration rate (eGFR), pointing to worsening renal function. The mild proteinuria persists, and the urinary sediment now shows an elevated number of red blood cells, signifying ongoing hematuria. These findings complicate Mr. Johnson's condition, necessitating a reevaluation of the treatment strategy and prompting a more aggressive approach to managing both his cardiovascular and urinary symptoms.

The multidisciplinary team reconvenes to discuss the implications of these developments. They recognize that while the dual therapy for BPH has provided some symptomatic relief, it may not be sufficient to address the overarching issues of renal deterioration and cardiovascular risk. Consequently, the team considers the need for surgical intervention, such as transurethral resection of the prostate (TURP), to provide more definitive relief of the bladder outlet obstruction. In parallel, they plan to collaborate with the cardiology team to optimize Mr. Johnson's antihypertensive regimen, ensuring that any changes do not exacerbate his urinary symptoms. This integrated approach aims to stabilize Mr. Johnson's renal function, improve his quality of life, and prevent further complications, marking the next critical phase in his treatment journey.

Section 5

New Diagnostic Results:

Following the decision to explore surgical intervention and optimize Mr. Johnson's antihypertensive regimen, the healthcare team conducts further diagnostic evaluations to guide their next steps. A renal ultrasound is performed to assess the structure and function of Mr. Johnson's kidneys, revealing mild hydronephrosis on the left side, likely due to persistent bladder outlet obstruction. This finding underscores the urgency of addressing the urinary retention more aggressively to prevent further renal damage.

Additionally, a 24-hour blood pressure monitoring study is conducted to gain a clearer picture of Mr. Johnson's hypertensive pattern. The results confirm significant fluctuations in his blood pressure, with peaks reaching as high as 160/100 mmHg during activity and dropping to 140/90 mmHg at rest. This variability suggests the current antihypertensive regimen may not be adequately controlling his blood pressure throughout the day, necessitating a more tailored pharmacological approach.

These new diagnostic results are pivotal in refining Mr. Johnson's treatment plan. The team discusses the potential benefits of adding a calcium channel blocker to his regimen, which could offer more consistent blood pressure control without compromising renal function. Meanwhile, the urology team schedules a TURP procedure, aiming to relieve the obstructive symptoms and, consequently, the hydronephrosis. By integrating these findings into the treatment strategy, the team hopes to stabilize Mr. Johnson's condition and prevent further complications, paving the way for improved clinical outcomes.